Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 28, 2016; 22(4): 1664-1673
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1664
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1664
| Etiologies of fatty liver disease |
| Frequent causes: |
| Non-alcoholic fatty liver disease |
| Alcoholic fatty liver disease |
| Chronic hepatitis C virus infection |
| Drug-induced steatosis |
| Less common or rare causes: |
| Inborn errors of metabolism (Wilson disease, abetalipoproteinemia, tyrosinaemia, hypobetalipoproteinemia) |
| Lipodystrophy (congenital or acquired) |
| Total parenteral nutrition |
| Surgical procedures (e.g., biliopancreatic diversion extensive small bowel resection) |
| Causes of drug-induced fatty liver disease |
| Predominantly microvesicular pattern: |
| Tetracyclin |
| Valproic acid |
| Amiodarone |
| Glucocorticoids |
| 5-FU |
| Margosa oil |
| Predominantly macrovesicular pattern: |
| Acetylsalicylic acid (intoxication) |
| Tamoxifen |
| Mixed pattern: |
| Antiretroviral agents (e.g., didanosine, stavudine) |
| Methotrexate |
- Citation: Ress C, Kaser S. Mechanisms of intrahepatic triglyceride accumulation. World J Gastroenterol 2016; 22(4): 1664-1673
- URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1664.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i4.1664
